First-Line Treatment of Trichinellosis
Trichinellosis requires a structured, evidence-based pharmacological regimen. Expert consensus supports a defined combination approach, and the full protocol details are accessible via the link below.
This protocol addresses first-line pharmacological management of Trichinellosis. It covers the selection of agents, the sequencing of the regimen, and the conditions under which the treatment cycle may be repeated.
Management is built around a combination of a diffusible anthelmintic agent together with a corticosteroid — the corticosteroid must not be administered alone. The specific agents, dosing, duration, and criteria for repeating the cycle are detailed in the full structured protocol.
References
DOI: 10.1128/cmr.00026-08
- However, on an empiric basis, most experts recommend the association of diffusible anthelminthics and corticosteroids (Dupouy-Camet et al., 2002).
- They must always be used in combination with anthelmintics and never alone, since they could increase the larval burden by delaying the intestinal worm expulsion.
View source ↗